Christian Glennie
Stock Analyst at Stifel Nicolaus
(2.73)
# 2,841
Out of 5,020 analysts
77
Total ratings
36%
Success rate
2.7%
Average return
Main Sectors:
Stocks Rated by Christian Glennie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 315p | 217p | +45.30% | 11 | Aug 4, 2026 | |
| AIM: AMS Advanced Medical Solutions Group plc | Reiterated: Buy | 245p | 282p | -12.97% | 12 | May 21, 2026 | |
| AIM: DXRX Diaceutics PLC | Reiterated: Buy | 225p | 192p | n/a | 10 | Sep 23, 2025 | |
| AIM: EKF EKF Diagnostics Holdings plc | Reiterated: Buy | 29p → 35p | 25p | n/a | 5 | Sep 16, 2025 | |
| LON: GNS Genus plc | Reiterated: Hold | 1,850p → 2,300p | 2,150p | n/a | 7 | Sep 9, 2025 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,650p | 1,571p | n/a | 8 | Apr 24, 2025 | |
| INDV Indivior Pharmaceuticals | Reiterated: Buy | $15 | $35.38 | n/a | 4 | Apr 24, 2025 | |
| AMS: PHARM Pharming Group N.V. | Reiterated: Buy | n/a | $0.8858 | n/a | 4 | Jun 4, 2024 | |
| AIM: AVCT Avacta Group Plc | Reiterated: Buy | 105p | 72p | n/a | 3 | May 23, 2024 | |
| BME: PHM Pharma Mar, S.A. | Downgraded: Hold | €109.00 | €70.75 | n/a | 1 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 4,441p → 4,071p | 5p | n/a | 3 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 7,031p → 5,551p | 44p | n/a | 2 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 15,394p → 13,914p | 73p | n/a | 4 | Jun 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 12,952p | 0.11p | n/a | 3 | May 18, 2017 |
Convatec Group PLC
Aug 4, 2026
Reiterated: Buy
Price Target: 315p
Current: 217p
Upside: +45.30%
Advanced Medical Solutions Group plc
May 21, 2026
Reiterated: Buy
Price Target: 245p
Current: 282p
Upside: -12.97%
Diaceutics PLC
Sep 23, 2025
Reiterated: Buy
Price Target: 225p
Current: 192p
Upside: n/a
EKF Diagnostics Holdings plc
Sep 16, 2025
Reiterated: Buy
Price Target: 29p → 35p
Current: 25p
Upside: n/a
Genus plc
Sep 9, 2025
Reiterated: Hold
Price Target: 1,850p → 2,300p
Current: 2,150p
Upside: n/a
Hikma Pharmaceuticals PLC
Apr 24, 2025
Reiterated: Buy
Price Target: 2,650p
Current: 1,571p
Upside: n/a
Indivior Pharmaceuticals
Apr 24, 2025
Reiterated: Buy
Price Target: $15
Current: $35.38
Upside: n/a
Pharming Group N.V.
Jun 4, 2024
Reiterated: Buy
Price Target: n/a
Current: $0.8858
Upside: n/a
Avacta Group Plc
May 23, 2024
Reiterated: Buy
Price Target: 105p
Current: 72p
Upside: n/a
Pharma Mar, S.A.
Nov 11, 2020
Downgraded: Hold
Price Target: €109.00
Current: €70.75
Upside: n/a
Jul 25, 2018
Reiterated: Buy
Price Target: 4,441p → 4,071p
Current: 5p
Upside: n/a
May 24, 2018
Reiterated: Buy
Price Target: 7,031p → 5,551p
Current: 44p
Upside: n/a
Jun 8, 2017
Reiterated: Buy
Price Target: 15,394p → 13,914p
Current: 73p
Upside: n/a
May 18, 2017
Reiterated: Buy
Price Target: 12,952p
Current: 0.11p
Upside: n/a